DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Angelika Martina Starzer,Gerwin Heller,Erwin Tomasich,Katharina Feldmann,Teresa Hatziioannou,Stefan Traint,Christoph Minichsdorfer,Ursula Schwarz-Nemec,Maja Nackenhorst,Leonhard Muellauer,Matthias Preusser,Anna S. Berghoff,Thorsten Fuereder

DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

2020

Angelika Martina Starzer
Gerwin Heller
Erwin Tomasich
Katharina Feldmann
Teresa Hatziioannou
Stefan Traint
Christoph Minichsdorfer
Ursula Schwarz-Nemec
Maja Nackenhorst
Leonhard Muellauer
Matthias Preusser
Anna S. Berghoff
Thorsten Fuereder

e18527Background: Biomarkers for response prediction to immune checkpoint inhibitors in head and neck squamous cell carcinoma (HNSCC) patients are needed for a personalized therapy regimen. Therefo...

Keywords:

Head and neck squamous-cell carcinoma
dna methylation profiling
Cancer research
Medicine
in patient
immune checkpoint inhibitors
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations